Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/28/2005 | EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
12/28/2005 | EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus |
12/28/2005 | EP1021204B1 Bioadhesive compositions and methods for topical administration of active agents |
12/28/2005 | EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
12/28/2005 | EP0945445B9 1,5-benzodiazepine derivatives |
12/28/2005 | CN1714096A Mmp inhibitors |
12/28/2005 | CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
12/28/2005 | CN1713906A Treatment of gastrointestinal disorders with duloxetine |
12/28/2005 | CN1713901A Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
12/28/2005 | CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid |
12/28/2005 | CN1713861A Vascularization enhanced graft constructs |
12/28/2005 | CN1233839C Productive method of recombinant human liver regenerated enhanced factor |
12/28/2005 | CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage |
12/28/2005 | CN1233663C Preparation of carboxymethyl chitin bismuth and its application in treating gastritis and gastrelcoma |
12/28/2005 | CN1233643C Ramification of a compound of medication as well as preparation method and application |
12/28/2005 | CN1233416C Compound pepsin powder for treating child dyspepsia and its preparation method |
12/28/2005 | CN1233409C Combination of Chinese traditional medicine for health preservation and preparation method |
12/28/2005 | CN1233407C Mixture of aucklandia root and garden burnet for easing stomach and its preparation |
12/28/2005 | CN1233406C Prescription for treating cholecystolithiasis |
12/28/2005 | CN1233401C Agastache capsule for restoring healthy energy and its preparation |
12/28/2005 | CN1233399C Effervescence tablet of radix isatidis and its preparation |
12/28/2005 | CN1233398C Medicine for treating stomatocace |
12/28/2005 | CN1233388C Medicinal composition for treating hepatitis |
12/28/2005 | CN1233371C Quick effect toothache plaster |
12/28/2005 | CN1233368C Medicine for treating chronic diarrhea |
12/28/2005 | CN1233364C Chinese medicine for treating digestive ulcerating sore and its preparation method |
12/28/2005 | CN1233359C Compound capsule of chicken-bone herb and its prodn. method |
12/28/2005 | CN1233357C Insect-ant capsule |
12/28/2005 | CN1233356C Method for preparing 'Yueju' capsule |
12/28/2005 | CN1233352C Hepatosis treating medicine |
12/28/2005 | CN1233349C Heat-clearing, toxin-expelling, swell-subsiding Chinese medicinal composition and its use |
12/28/2005 | CN1233345C Chinese proprietary drug for treating cholelithiasis |
12/28/2005 | CN1233339C Powdered medicine for treating viral hepatitis B |
12/28/2005 | CN1233338C Mark-removing capsule |
12/28/2005 | CN1233318C Hepadestal soft capsule and its preparing method |
12/28/2005 | CN1233317C Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process |
12/28/2005 | CN1233257C A composition containing carvacrol and thymol for use as abactericide |
12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
12/27/2005 | US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
12/27/2005 | US6979683 Polymerase enzyme inhibitors |
12/27/2005 | US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors |
12/27/2005 | CA2156287C Indolin-2-one derivative |
12/22/2005 | WO2005121312A1 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
12/22/2005 | WO2005121135A1 Vla-4 inhibitor |
12/22/2005 | WO2005121123A1 Compounds as cor5 antagonists |
12/22/2005 | WO2005120527A1 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
12/22/2005 | WO2005120491A1 Remedy or preventive for inflammatory bowel disease |
12/22/2005 | WO2005120485A1 Regulator of physiological function of ghrelin and use thereof |
12/22/2005 | WO2005120484A1 Regulator for physiological functions of ghrelin |
12/22/2005 | WO2005120467A2 Dosage form containing the active ingredient cholylsarcosine |
12/22/2005 | WO2005080397A3 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
12/22/2005 | WO2004093823A3 Polyethelene glycol link glp-1 compounds |
12/22/2005 | WO2003057856A3 Dominant negative proteins and methods thereof |
12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/22/2005 | US20050282900 Inhibitors of alpha4 mediated cell adhesion |
12/22/2005 | US20050282889 Intracorporeal medicaments for photodynamic treatment of disease |
12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
12/22/2005 | US20050282875 Pyrrolidinium derivatives |
12/22/2005 | US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione |
12/22/2005 | US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis |
12/22/2005 | US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
12/22/2005 | US20050282852 Preventive and therapeutic medicament for gastroesophageal reflux disease |
12/22/2005 | US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity |
12/22/2005 | US20050282798 Pharmaceutical compounds |
12/22/2005 | US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
12/22/2005 | US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations |
12/22/2005 | US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators |
12/22/2005 | US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents |
12/22/2005 | US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
12/22/2005 | US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides |
12/22/2005 | US20050281910 Method for increasing pet activity |
12/22/2005 | US20050281885 Method for treating inflammatory bowel disease by oral administration of IL-10 |
12/22/2005 | US20050281818 Method for the treatment of fibrosis |
12/22/2005 | US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer |
12/22/2005 | US20050281756 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
12/22/2005 | DE20023736U1 Compositions comprising American ginseng and/or its extract for the prevention and treatment of gastro-duodenal ulcers |
12/22/2005 | CA2569678A1 Regulator of physiological function of ghrelin and use thereof |
12/22/2005 | CA2567063A1 Dosage form containing the active ingredient cholylsarcosine |
12/21/2005 | EP1607395A1 Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
12/21/2005 | EP1607394A1 Water-soluble thalidomine derivatives |
12/21/2005 | EP1607387A2 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists |
12/21/2005 | EP1607103A1 Concomitant drug as therapeutic agent for inflammatory bowel disease |
12/21/2005 | EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein |
12/21/2005 | EP1607091A1 Antihepatitis c virus agent and anti-hiv agent |
12/21/2005 | EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome |
12/21/2005 | EP1607088A1 Controlled release composition |
12/21/2005 | EP1607087A1 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis |
12/21/2005 | EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
12/21/2005 | EP1606279A1 Polymorphs of s-omeprazole |
12/21/2005 | EP1605975A1 Composition and method for the treatment and prevention of enteric bacterial infections |
12/21/2005 | EP1605926A1 Use of pinitol or chiroinositol for protecting the liver |
12/21/2005 | EP1605897A2 Polyethelene glycol link glp-1 compounds |
12/21/2005 | EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
12/21/2005 | EP1468075B1 Novel lactobacillus sp. strain and use thereof |
12/21/2005 | EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
12/21/2005 | EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
12/21/2005 | EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
12/21/2005 | EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |